Xi-Ran He
Peking University
11 Papers
102 Citations
Xi-Ran He is an academic researcher from Peking University. The author has contributed to research in topics: Apoptosis & In vivo. The author has an hindex of 7, co-authored 11 publications.
Chat about Author
Papers
Acupuncture and Moxibustion for Cancer-related Fatigue: a Systematic Review and Meta-analysis
Xi-Ran He,Quan Wang,Ping-Ping Li +2 more
TL;DR: Evaluating the auxiliary effectiveness of acupuncture and moxibustion in the treatment of CRF found the combination had a relatively significant benefit in improving severe fatigue and QLQ-C30.
57
MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma
Shu-Yan Han,Hai-Bo Han,Xiu-Yun Tian,Hong Sun,Dong Xue,Can Zhao,Shan-Tong Jiang,Xi-Ran He,Wen-Xian Zheng,Jing Wang,Li-Na Pang,Xiao-Hong Li,Ping-Ping Li +12 more
TL;DR: It is suggested that miR-33a-3p suppressed the malignant phenotype while also inhibiting PBX3 expression in hepatocellular cancer, implying that miRs may be a promising biomarkers and therapy target for HCC intervention.
Simultaneous determination of gefitinib and its major metabolites in mouse plasma by HPLC-MS/MS and its application to a pharmacokinetics study.
Nan Zheng,Can Zhao,Xi-Ran He,Shan-Tong Jiang,Shu-yan Han,Shu-yan Han,Guobing Xu,Ping-Ping Li,Ping-Ping Li +8 more
TL;DR: A simple, rapid and credible high performance liquid chromatography-tandem mass spectrometry method was established and validated for the simultaneous quantification of gefitinib and its main metabolites in NSCLC tumor-bearing mouse plasma.
39
Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
Xi-Ran He,Shu-Yan Han,Xiao-Hong Li,Wen-Xian Zheng,Wen-Xian Zheng,Li-Na Pang,Shan-Tong Jiang,Ping-Ping Li +7 more
TL;DR: It is suggested that BFD could dose-dependently suppress EMT induced by TGF-β1 in vitro via attenuating canonical Smad signaling pathway, and then help contribute to create a relatively steady microenvironment for confining lung cancer.
29
Recent highlights of Chinese medicine for advanced lung cancer.
TL;DR: It is concluded that CM can offer better overall therapeutic benefits when used in combination with routine Western medicine for patients with advanced lung cancer.
13